Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Estradiol dienanthate is a long-acting synthetic ester of estradiol, functioning as a prodrug that is hydrolyzed in the body to release active estradiol. It acts as an agonist of the estrogen receptor, exerting estrogenic effects. Historically, it was used in menopausal hormone therapy to alleviate symptoms such as hot flashes, vaginal dryness, and mood changes, and also for contraception (as a component of combination drugs) and lactation suppression. It was typically administered via intramuscular injection. First described in 1959, it was available in Canada and Germany but was discontinued by 2005 and is no longer available in any form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Estradiol dienanthate.